Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Indicates Optimism Prevnar 13 Will Show Clinical Benefit In Confirmatory Trial

Nov 17 2011

• By Derrick Gingery

Related Content

Prevnar 13 In Older Adults Appears To Have Smooth Path To FDA Approval

Nov 14 2011

Pfizer Touts <i>Prevnar 13</i> Superiority As Initial Vaccine In Older Persons Before ACIP

Oct 31 2011

Related Companies

Pfizer Inc.

Merck & Co., Inc.

Additional Topics

Advisory Committees BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window